Strengthen prescription monitoring and auditing
Expand access to evidence-based addiction treatment
Improve drug testing and quality control
Increase transparency in pharmaceutical marketing and lobbying
Enforce stricter penalties for fraud and misconduct
Protect whistleblowers and encourage reporting
Train healthcare workers on safe prescribing
Limit overprescribing through clinical guidelines
Improve public education on drug risks
Increase funding for prevention and recovery services
Coordinate law enforcement, regulators, and public health agencies
Hold companies and individuals accountable in court
Support independent investigations and oversight
Reduce stigma around substance use disorder
Expand access to naloxone and overdose prevention tools